Ryan Stowe Ryan Stowe, Ph.D., received his Ph.D. from the Scripps Research Institute. Technologies Benzoylhydrazide HDAC Inhibitors with Low Toxicity for Treating Cancer Anticancer Compounds That Selectively Target and Destroy Cancer-Related Proteins
